Study: CFS biomarkers at the time of diagnosis may aid in MS prognosis
Certain biomarkers in the cerebrospinal fluid (CSF) — the fluid surrounding the brain and spinal cord — around the time of a multiple sclerosis (MS) diagnosis may help predict the time to reaching certain disability milestones among people with a relapsing-remitting (RRMS) disease course, according to findings from a recent study. Such markers also were associated with short-term relapse […]